Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation.

[1]  A. Schuchat,et al.  Prevention of Varicella: Recommendations for Use of Varicella Vaccines in Children, Including a Recommendation for a Routine 2-Dose Varicella Immunization Schedule , 2007, Pediatrics.

[2]  A. Toschke,et al.  Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia , 2007, British journal of haematology.

[3]  C. Ohmann,et al.  Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[4]  R. Borrow,et al.  Revaccination of children after completion of standard chemotherapy for acute leukemia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Borrow,et al.  Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Roivainen,et al.  A randomized study on donor immunization with tetanus–diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation , 2007, Bone Marrow Transplantation.

[7]  A. Groll,et al.  Bordetella pertussis respiratory infection following hematopoietic stem cell transplantation: time for universal vaccination? , 2006, Bone Marrow Transplantation.

[8]  C. Pannuti,et al.  The benefit of influenza vaccination after bone marrow transplantation , 2005, Bone Marrow Transplantation.

[9]  A. Ozkan,et al.  Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia , 2005, Journal of pediatric hematology/oncology.

[10]  F. Fregonese,et al.  Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy , 2005, Cancer.

[11]  H. Einsele,et al.  Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT , 2005, Bone Marrow Transplantation.

[12]  C. Pannuti,et al.  Early measles vaccination in bone marrow transplant recipients , 2005, Bone Marrow Transplantation.

[13]  A. Plebani,et al.  Re‐immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy , 2005, European journal of haematology.

[14]  P. Ljungman,et al.  Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients , 2004, Bone Marrow Transplantation.

[15]  J. Abrahamsson,et al.  Intensive Treatment for Childhood Acute Lymphoblastic Leukemia Reduces Immune Responses to Diphtheria, Tetanus, and Haemophilus influenzae Type b , 2004, Journal of pediatric hematology/oncology.

[16]  P. Ljungman,et al.  Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease , 2004, Bone Marrow Transplantation.

[17]  M. Giannaki,et al.  Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants , 2004, Bone Marrow Transplantation.

[18]  Chi-kong Li,et al.  Immunogenicity of a two‐dose regime of varicella vaccine in children with cancers , 2004, European journal of haematology.

[19]  D. Maloney,et al.  Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation , 2004, Bone Marrow Transplantation.

[20]  J. Madrigal,et al.  Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients , 2003, Bone Marrow Transplantation.

[21]  S. Trocciola,et al.  Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. , 2003, Blood.

[22]  M. Ussowicz,et al.  Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery , 2002, British journal of haematology.

[23]  A. Finn,et al.  Royal College of Paediatrics and Child Health (RCPCH) best practice statement on immunisation in the immunocompromised child , 2002 .

[24]  P. Ljungman,et al.  Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey , 2002, British journal of haematology.

[25]  D. Douek,et al.  Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1 , 2002, Transplantation.

[26]  B. Storer,et al.  Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. , 2002, Blood.

[27]  S. Mackinnon,et al.  Excessive T cell depletion of peripheral blood stem cells has an adverse effect upon outcome following allogeneic stem cell transplantation , 2001, Bone Marrow Transplantation.

[28]  D. Neuberg,et al.  Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. , 2001, Blood.

[29]  D. Maloney,et al.  Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. , 2001, Blood.

[30]  S. Kaplan,et al.  Pneumococcal infections in children after transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  A. Charlett,et al.  Response to influenza immunisation during treatment for cancer , 2001, Archives of disease in childhood.

[32]  Ó. Jónsson,et al.  IMMUNOGLOBULIN CLASS AND SUBCLASS CONCENTRATIONS AFTER TREATMENT OF CHILDHOOD LEUKEMIA , 2001, Pediatric hematology and oncology.

[33]  J. Ioannidis,et al.  Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. , 2000, The Journal of infectious diseases.

[34]  J. Jüngert,et al.  Humoral immunity against diphtheria, tetanus and poliomyelitis after antineoplastic therapy in children and adolescents--a retrospective analysis. , 2000, Vaccine.

[35]  S. Singhal,et al.  Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. , 2000, Blood.

[36]  D. Dennis,et al.  Surveillance for Lyme disease--United States, 1992-1998. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[37]  P. Ljungman,et al.  Serum immunoglobulin levels in relation to levels of specific antibodies in allogeneic and autologous bone marrow transplant recipients. , 2000, Transplantation.

[38]  J. Hermans,et al.  Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation , 2000, Bone Marrow Transplantation.

[39]  R C George,et al.  Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis , 2000, BMJ : British Medical Journal.

[40]  C. Wheeler,et al.  Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation , 1998, Bone Marrow Transplantation.

[41]  M. Andrew,et al.  Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  A. Pession,et al.  Immunization with Haemophilus influenzae Type b Conjugate Vaccine in Children Given Bone Marrow Transplantation: Comparison with Healthy Age-Matched Controls , 1998, Journal of Clinical Immunology.

[43]  C. Pui,et al.  Profound abnormality of the B/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia , 1998, Leukemia.

[44]  P. Ruutu,et al.  Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT , 1997, Bone Marrow Transplantation.

[45]  P. Ruutu,et al.  A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT , 1997, Bone Marrow Transplantation.

[46]  K. Sepkowitz,et al.  A national survey of immunization practices following allogeneic bone marrow transplantation. , 1997, JAMA.

[47]  S. King,et al.  Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. , 1996, Bone marrow transplantation.

[48]  P. Ruutu,et al.  Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[49]  V. Bonagura,et al.  Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy. , 1995, The Journal of pediatrics.

[50]  F. Locatelli,et al.  Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation , 1995, Journal of Clinical Immunology.

[51]  H. Einsele,et al.  Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. , 1995, Bone marrow transplantation.

[52]  J. Abrahamsson,et al.  Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow‐up , 1995, Acta paediatrica.

[53]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[54]  G. Gahrton,et al.  Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. , 1994, Blood.

[55]  T. Pelliniemi,et al.  Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. , 1994, Pediatric hematology and oncology.

[56]  S. Sallan,et al.  Polysaccharide conjugate vaccine responses in bone marrow transplant patients. , 1994, Transplantation.

[57]  C. Cordonnier,et al.  Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. , 1992, The Journal of infectious diseases.

[58]  P. Ljungman,et al.  Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. , 1992, Bone marrow transplantation.

[59]  T. Salmi,et al.  Recovery of blood B‐lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia , 1992, Cancer.

[60]  L. Kaplan,et al.  Severe measles in immunocompromised patients. , 1992, JAMA.

[61]  R. Handsher,et al.  Immune response to polio vaccination in bone marrow transplant recipients. , 1991, Bone marrow transplantation.

[62]  D. Ridgway,et al.  Immunization response varies with intensity of acute lymphoblastic leukemia therapy. , 1991, American journal of diseases of children.

[63]  P. Ljungman,et al.  Response to immunization against polio after allogeneic marrow transplantation. , 1991, Bone marrow transplantation.

[64]  M. Pepe,et al.  Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. , 1990, The Journal of infectious diseases.

[65]  P. Roberson,et al.  Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. , 1990, The Journal of infectious diseases.

[66]  J. Sheridan,et al.  Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. , 1990, Blood.

[67]  A. Gershon,et al.  Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. , 1989, The New England journal of medicine.

[68]  G. Gahrton,et al.  Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. , 1989, The Journal of infectious diseases.

[69]  J. Fehr,et al.  Functional hyposplenia after allogeneic bone marrow transplantation is detected by epinephrine stimulation test and splenic ultrasonography , 1988, European journal of haematology.

[70]  I. Weissman,et al.  Total lymphoid irradiation leads to transient depletion of the mouse thymic medulla and persistent abnormalities among medullary stromal cells. , 1988, Journal of immunology.

[71]  S. Feldman,et al.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis. , 1987, Pediatrics.

[72]  L. Lum.  The kinetics of immune reconstitution after human marrow transplantation. , 1987, Blood.

[73]  R. Storb,et al.  The detection of specific antibody formation to recall antigens after human bone marrow transplantation. , 1986, Blood.

[74]  M. Harada,et al.  T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. , 1984, Transplantation.

[75]  S. Feig,et al.  Pneumococcal vaccination of recipients of bone marrow transplants. , 1983, Archives of internal medicine.

[76]  R. Storb,et al.  In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. , 1981, Blood.

[77]  S. Feig,et al.  Pneumococcal infections after human bone-marrow transplantation. , 1979, Annals of internal medicine.

[78]  W. Krivit.  Overwhelming postsplenectomy infection , 1977, American journal of hematology.

[79]  A. Casas,et al.  Humoral immunity in pediatric patients with acute lymphoblastic leukaemia , 2003 .

[80]  D. Bernstein,et al.  Infant heart transplantation at Stanford: growth and neurodevelopmental outcome. , 2002, Pediatrics.

[81]  P. Engström,et al.  Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. , 2002, Pediatrics.

[82]  C. Pannuti,et al.  Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. , 2002, Blood.

[83]  M. Björkholm,et al.  Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. , 2000, Haematologica.

[84]  A. Nagler,et al.  Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. , 1993, Bone marrow transplantation.

[85]  M. Potter,et al.  Immune reconstitution after BMT in children. , 1993, Bone marrow transplantation.